Editas Medicine (EDIT) Return on Assets (2016 - 2025)

Editas Medicine (EDIT) has 10 years of Return on Assets data on file, last reported at 0.01% in Q4 2025.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.01% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01% (changed 0.0% YoY) and the FY2024 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Assets rose to 0.01% in Q4 2025 per EDIT's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q1 2021 and bottomed at 0.01% in Q2 2025.
• The 5-year median for Return on Assets is 0.0% (2023), against an average of 0.0%.
• The widest annual swing landed in 2021, when Return on Assets changed 0 bps; it then fell 1 bps in 2025.
• Tracing EDIT's Return on Assets over 5 years: stood at 0.0% in 2021, then tumbled by 53 bps to 0.0% in 2022, then grew by 28 bps to 0.0% in 2023, then sank by 135 bps to 0.01% in 2024, then decreased by 11 bps to 0.01% in 2025.
• Per Business Quant, the three latest EDIT Return on Assets figures stand at 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).

Peer Comparison